Universe Pharmaceuticals (UPC) Common Equity: 2019-2024
Historic Common Equity for Universe Pharmaceuticals (UPC) over the last 6 years, with Sep 2024 value amounting to $45.5 million.
- Universe Pharmaceuticals' Common Equity rose 62.68% to $45.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $45.5 million, marking a year-over-year increase of 62.68%. This contributed to the annual value of $45.5 million for FY2024, which is 62.68% up from last year.
- Latest data reveals that Universe Pharmaceuticals reported Common Equity of $45.5 million as of FY2024, which was up 62.68% from $28.0 million recorded in FY2023.
- In the past 5 years, Universe Pharmaceuticals' Common Equity registered a high of $47.0 million during FY2021, and its lowest value of $20.8 million during FY2020.
- Its 3-year average for Common Equity is $36.3 million, with a median of $35.3 million in 2022.
- In the last 5 years, Universe Pharmaceuticals' Common Equity skyrocketed by 125.89% in 2021 and then decreased by 24.82% in 2022.
- Yearly analysis of 5 years shows Universe Pharmaceuticals' Common Equity stood at $20.8 million in 2020, then skyrocketed by 125.89% to $47.0 million in 2021, then declined by 24.82% to $35.3 million in 2022, then decreased by 20.83% to $28.0 million in 2023, then soared by 62.68% to $45.5 million in 2024.